Researchers have found that Namenda (memantine)from Merz boosts memory function in those with Down's Syndrome, a major milestone in the...
On 18 October 2012, the CHMP adopted a negative opinion, recommending the refusal of the marketing authorisation for the combination...
Merz Neurosciences, a division of Merz North America, has submitted an sBLA to the FDA to seek approval for the...